Qube Research & Technologies (QRT)
GSK icon

Qube Research & Technologies (QRT)’s GSK GSK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-400
Closed -$15.5K – 3703
2025
Q1 		$15.5K Hold
400
– – ﹤0.01% 3244
2024
Q4 		$13.5K Buy
+400
New +$14.4K ﹤0.01% 3218

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GSK Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in GSK (GSK) in Q1 2026: 548,222 shares worth $30.3M. The stake represents 0.03% of the portfolio and ranks #646 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in GSK as recently as Q3 2024.

Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 16 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Qube Research & Technologies (QRT) held 548,222 shares of GSK worth $30.3M as of Q1 2026.
  • GSK was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • GSK made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #646 holding.
  • Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 16 quarters since.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.